313 related articles for article (PubMed ID: 18486229)
1. Magnetic resonance imaging as an approach towards identifying neuropathological biomarkers for Huntington's disease.
Bohanna I; Georgiou-Karistianis N; Hannan AJ; Egan GF
Brain Res Rev; 2008 Jun; 58(1):209-25. PubMed ID: 18486229
[TBL] [Abstract][Full Text] [Related]
2. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques.
Rizk-Jackson A; Stoffers D; Sheldon S; Kuperman J; Dale A; Goldstein J; Corey-Bloom J; Poldrack RA; Aron AR
Neuroimage; 2011 May; 56(2):788-96. PubMed ID: 20451620
[TBL] [Abstract][Full Text] [Related]
3. Brain structure in preclinical Huntington's disease.
Paulsen JS; Magnotta VA; Mikos AE; Paulson HL; Penziner E; Andreasen NC; Nopoulos PC
Biol Psychiatry; 2006 Jan; 59(1):57-63. PubMed ID: 16112655
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted imaging in Huntington's disease.
Seppi K; Schocke MF; Mair KJ; Esterhammer R; Weirich-Schwaiger H; Utermann B; Egger K; Brenneis C; Granata R; Boesch S; Poewe W; Wenning GK
Mov Disord; 2006 Jul; 21(7):1043-7. PubMed ID: 16570300
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiological measures as potential biomarkers in Huntington's disease: review and future directions.
Nguyen L; Bradshaw JL; Stout JC; Croft RJ; Georgiou-Karistianis N
Brain Res Rev; 2010 Sep; 64(1):177-94. PubMed ID: 20381528
[TBL] [Abstract][Full Text] [Related]
6. Change in MRI striatal volumes as a biomarker in preclinical Huntington's disease.
Aylward EH
Brain Res Bull; 2007 Apr; 72(2-3):152-8. PubMed ID: 17352939
[TBL] [Abstract][Full Text] [Related]
7. The search for neuroimaging biomarkers of Alzheimer's disease with advanced MRI techniques.
Li TQ; Wahlund LO
Acta Radiol; 2011 Mar; 52(2):211-22. PubMed ID: 21498351
[TBL] [Abstract][Full Text] [Related]
8. fMRI reveals altered auditory processing in manifest and premanifest Huntington's disease.
Saft C; Schüttke A; Beste C; Andrich J; Heindel W; Pfleiderer B
Neuropsychologia; 2008 Apr; 46(5):1279-89. PubMed ID: 18221758
[TBL] [Abstract][Full Text] [Related]
9. Prefrontal cortex volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number.
Gómez-Ansón B; Alegret M; Muñoz E; Monté GC; Alayrach E; Sánchez A; Boada M; Tolosa E
Parkinsonism Relat Disord; 2009 Mar; 15(3):213-9. PubMed ID: 18632301
[TBL] [Abstract][Full Text] [Related]
10. Development of biomarkers for Huntington's disease.
Weir DW; Sturrock A; Leavitt BR
Lancet Neurol; 2011 Jun; 10(6):573-90. PubMed ID: 21601164
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of high and ultra high-field MRI.
Nakada T
Brain Dev; 2007 Jul; 29(6):325-35. PubMed ID: 17113259
[TBL] [Abstract][Full Text] [Related]
12. Picturing multiple sclerosis: conventional and diffusion tensor imaging.
Fox RJ
Semin Neurol; 2008 Sep; 28(4):453-66. PubMed ID: 18843574
[TBL] [Abstract][Full Text] [Related]
13. High-resolution magnetic resonance imaging sinc-interpolation-based subvoxel registration and semi-automated quantitative lateral ventricular morphology employing threshold computation and binary image creation in the study of fatty acid interventions in schizophrenia, depression, chronic fatigue syndrome and Huntington's disease.
Puri BK
Int Rev Psychiatry; 2006 Apr; 18(2):149-54. PubMed ID: 16777669
[TBL] [Abstract][Full Text] [Related]
14. Advanced magnetic resonance imaging metrics: implications for multiple sclerosis clinical trials.
Zivadinov R
Methods Find Exp Clin Pharmacol; 2009; 31(1):29-40. PubMed ID: 19357796
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in Huntington's and Parkinson's Disease.
O'Keeffe GC; Michell AW; Barker RA
Ann N Y Acad Sci; 2009 Oct; 1180():97-110. PubMed ID: 19906264
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal neuroimaging biomarkers in Huntington's Disease.
Rees EM; Scahill RI; Hobbs NZ
J Huntingtons Dis; 2013; 2(1):21-39. PubMed ID: 25063427
[TBL] [Abstract][Full Text] [Related]
17. Perfusion magnetic resonance imaging in psychiatry.
Théberge J
Top Magn Reson Imaging; 2008 Apr; 19(2):111-30. PubMed ID: 19363433
[TBL] [Abstract][Full Text] [Related]
18. Brain imaging in drug R&D.
Zijdenbos AP; Lerch JP; Bedell BJ; Evans AC
Biomarkers; 2005 Nov; 10 Suppl 1():S58-68. PubMed ID: 16298913
[TBL] [Abstract][Full Text] [Related]
19. Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders.
Agosta F; Canu E; Sarro L; Comi G; Filippi M
Cortex; 2012 Apr; 48(4):389-413. PubMed ID: 21632046
[TBL] [Abstract][Full Text] [Related]
20. Structural Magnetic Resonance Imaging in Huntington's Disease.
Wilson H; Dervenoulas G; Politis M
Int Rev Neurobiol; 2018; 142():335-380. PubMed ID: 30409258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
